Pablo Mandó

ORCID

Publication Activity (10 Years)

Years Active: 2023-2024
Publications (10 Years): 4

Top Venues

OncoTargets and therapy

JCO global oncology

International journal of molecular sciences

This page only lists publications with an associated author ORCID identifier.

Publications

Ayelén Ivana Pesce Viglietti, María Belén Bordignon, Alexis Ostinelli, Manglio Miguel Rizzo, Gerardo R Cueto, María Belén Sanchez, Florencia Perazzo, Mora Amat, Federico Coló, María Victoria Costanzo, Adrián Nervo, Jorge Nadal, Gabriel Crimi, Ignacio L McLean, Eunice Amancay Spengler, José Mordoh, Pablo Mandó, Estrella Mariel Levy
In-Depth Analysis of the Peripheral Immune Profile of HER2+ Breast Cancer Patients on Neoadjuvant Treatment with Chemotherapy Plus Trastuzumab Plus Pertuzumab. International journal of molecular sciences 25 (17) (2024)
Federico Waisberg, Pablo Mandó, Carolina Almada, Naima Kassis, Andrea Mainella, Luciano Cermignani, María Cecilia Riggi, Melina Winocur, Ramiro González, Andres Guercovich, Natalia Ayala, Cristian Micheri, Ana Carolina Ituarte, Lucía González Mattos, Pamela Llugdar, Mónica Casalnuovo, Maribel Lutteral, Sebastián Cinquini, Alejandro Mazzotta, Janeth Lara Alcantara, Rosa Penayo, Gonzalo Gomez-Abuin
Determining Clinicopathologic Factors That Influence Treatment in Advanced Breast Cancer in Argentina After CDK4/6 Inhibitors. JCO global oncology 10 (2024)
Pablo Mandó, Federico Waisberg, Rosario Pasquinelli, Sergio Rivero, Alexis Ostinelli, Florencia Perazzo
HER2-Directed Therapy in Advanced Breast Cancer: Benefits and Risks. OncoTargets and therapy 16 (2023)
Pablo Mandó, Federico Waisberg, Rosario Pasquinelli, Sergio Rivero, Alexis Ostinelli, Florencia Perazzo
HER2-Directed Therapy in Advanced Breast Cancer: Benefits and Risks. OncoTargets and therapy 16 (2023)

Pablo Mandó.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Pablo Mandó